Executive Vice President and Chief Financial Officer
AxoGen is a biotech company developing treatment options for the reconstruction and repair of peripheral nerve injuries.
Experienced Executive and Chief Financial Officer with broad commercial and operational experience in collaborative, high-growth organizations driving integration, operational improvement, revenue growth and strategic planning in public and pre-IPO settings. Proven track record of leadership and developing professional, high performing teams, and collaborative strategic partnerships with CEO, executive teams and boards. Extensive international experience. Significant public markets experience including successful raises of equity, debt and strategic financing; driving strong, consistent investor communication and strategies; and establishing solid SEC reporting structures. Experienced with strategic acquisitions and integration, lean process implementation and continuous improvement. Experience in commercial strategy development and implementation, including presentation and close of large capital sales transactions.